Liquid biopsy in non-small-cell lung cancer: Ready for prime time?

Liquid biopsy in non-small-cell lung cancer: Ready for prime time?

Bibliographic Details
Main Authors:	Mansi Sharma, Srujana Joga, Ullas Batra
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Cancer Research, Statistics, and Treatment
Online Access:	http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=1;spage=142;epage=143;aulast=Sharma

Similar Items

First-line treatment of EGFR-mutant NSCLC: Spoiled for choice?
by: Ullas Batra, et al.
Published: (2019-01-01)

Molecular tumor boards: Demystifying complex algorithms in non-small cell lung cancer
by: Ullas Batra, et al.
Published: (2020-01-01)

Detection of rare targetable EGFR variant in Metastatic Non-small Cell Lung Carcinoma by next Generation Sequencing: A Case Report
by: Anurag Mehta, et al.
Published: (2020-06-01)

Association of Vitamin D with cancer – Catch me if you can!
by: Ullas Batra, et al.
Published: (2020-01-01)

Update on liquid biopsy in clinical management of non-small cell lung cancer
by: Wu Z, et al.
Published: (2019-07-01)

Liquid biopsies of solid tumors: non-small-cell lung and pancreatic cancer
by: Kalubowilage, Madumali
Published: (2017)

Future directions and management of liquid biopsy in non-small cell lung cancer
by: Alessia Maria Cossu, et al.
Published: (2020-08-01)

Management of incidental nodules in lung cancer screening: ready for prime-time?
by: Nikolaos I. Kanellakis, et al.
Published: (2019-12-01)

Biomarker testing in non-small cell lung carcinoma – More is better: A case series
by: Ullas Batra, et al.
Published: (2020-01-01)

The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer
by: D. Akhoundova, et al.
Published: (2020-11-01)

Current status and future perspectives of liquid biopsy in non-small cell lung cancer
by: Sunhee Chang, et al.
Published: (2020-05-01)

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
by: Jatta Saarenheimo, et al.
Published: (2019-03-01)

The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
by: Yi-Chen Zhang, et al.
Published: (2017-10-01)

Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
by: Misako Nagasaka, et al.
Published: (2021-06-01)

EGFR mutation in non-small cell lung cancer by liquid biopsy when solid not feasible
by: Kirti Chadha, et al.
Published: (2020-01-01)

Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?
by: Fiorella Calabrese, et al.
Published: (2019-03-01)

Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
by: Umberto Malapelle, et al.
Published: (2021-08-01)

Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
by: Lanxiang Huang, et al.
Published: (2021-05-01)

Cancer Biomarkers: Are We Ready for the Prime Time?
by: Alok Mishra, et al.
Published: (2010-03-01)

Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure
by: Juan Zhou, et al.
Published: (2019-04-01)

Advances in Liquid Biopsy and its Clinical Application in the Diagnosis  and Treatment of Non-small Cell Lung Cancer
by: Difan ZHENG, et al.
Published: (2016-06-01)

Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkers
by: Giovanni Vicidomini, et al.
Published: (2020-10-01)

Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic
by: Maria Gabriela O. Fernandes, et al.
Published: (2021-07-01)

Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital
by: Venkata Pradeep Babu Koyyala, et al.
Published: (2018-01-01)

Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?
by: Victoria Heredia-Soto, et al.
Published: (2021-04-01)

REBOA: is it ready for prime time?
by: Jay Doucet, et al.

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time?
by: Paul Hofman, et al.
Published: (2019-02-01)

Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
by: Patricia Mondelo-Macía, et al.
Published: (2021-01-01)

BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy
by: Ming Li, et al.
Published: (2021-01-01)

Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer
by: Federico Cucchiara, et al.
Published: (2020-12-01)

Liquid biopsy in lung cancer-hope or hype?
by: Anuradha Choughule, et al.
Published: (2019-01-01)

Liquid Biopsy in Small Cell Lung Cancer—A Route to Improved Clinical Care?
by: Matt Church, et al.
Published: (2020-12-01)

Radiotherapy for HCC: Ready for prime time?
by: Andrew Bang, et al.
Published: (2019-08-01)

Renal Denervation: Is It Ready for Prime Time?
by: Lauder, Lucas, et al.
Published: (2020)

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib
by: Riziero Esposito Abate, et al.
Published: (2019-09-01)

Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle
by: Elien Augustus, et al.
Published: (2021-04-01)

Progress of Liquid Biopsy in Early Diagnosis of Lung Cancer
by: Zhipeng SONG, et al.
Published: (2018-08-01)

The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
by: Cláudia Freitas, et al.
Published: (2021-04-01)

Authors' reply to Rasalkar et al.
by: Ullas Batra, et al.
Published: (2021-01-01)

NTRK-A narrative review
by: Ullas Batra, et al.
Published: (2021-01-01)